What is the recommended dose of Vitamin A (Vit A) for a child with measles?

Vitamin A Dosing for Children with Measles

All children with measles should receive vitamin A supplementation: 200,000 IU orally for children ≥12 months and 100,000 IU for children <12 months, with a second dose repeated on day 2. 1, 2

Standard Dosing Protocol

Age-Based Dosing

• Children ≥12 months: 200,000 IU orally on day 1, followed by 200,000 IU on day 2 1, 3
• Children <12 months (including infants <6 months): 100,000 IU orally on day 1, followed by 100,000 IU on day 2 1, 2

Clinical Rationale

The two-dose regimen is specifically indicated for all children with measles, particularly those with complications including pneumonia, otitis media, croup, diarrhea with dehydration, or neurological problems. 1 This recommendation applies regardless of whether vitamin A deficiency is clinically apparent, as 92% of hospitalized children with measles demonstrate biochemical hyporetinemia. 4

Evidence for Mortality Reduction

The two-dose regimen of 200,000 IU reduces overall mortality by 64% and pneumonia-specific mortality by 67%. 3 The benefit is most pronounced in children under 2 years of age, where mortality reduction reaches 82%. 3 In contrast, a single dose of 200,000 IU has not been shown to reduce mortality (RR 0.77; 95% CI 0.34-1.78). 3

Key Study Findings

• Children receiving two doses of vitamin A had 7% mortality versus 13% in controls, with the difference most significant in children under 2 years (2% versus 17% mortality). 5
• Hospital stay duration decreased from 13 days to 10 days with vitamin A supplementation. 6
• Intensive care requirements dropped from 10.5% to 4.3% with treatment. 6

Extended Dosing for Eye Symptoms

If any eye symptoms of vitamin A deficiency are present (xerosis, Bitot's spots, keratomalacia, or corneal ulceration), administer a third dose of 200,000 IU at 1-4 weeks after the initial two doses. 1 This extended protocol addresses the underlying vitamin A deficiency that predisposes to severe measles complications.

Critical Implementation Points

Timing and Administration

• Begin vitamin A immediately upon clinical diagnosis of measles—do not delay waiting for laboratory confirmation. 2
• Vitamin A is the only evidence-based intervention proven to reduce measles mortality in children. 1, 2
• The standard protocol carries no toxicity risk, as acute toxicity requires >300,000 IU in adults or >60,000 IU in children within hours to days. 1

Common Pitfalls to Avoid

• Never use a single dose regimen: Single-dose vitamin A (200,000 IU once) has not demonstrated mortality benefit and should not be used. 3, 7
• Do not withhold due to perceived adequate nutrition: Even in populations where clinical vitamin A deficiency is rare, children with measles demonstrate marked biochemical deficiency (mean serum retinol 0.405 μmol/L). 4
• Do not forget the second dose: The mortality reduction is specifically associated with the two-dose regimen given on consecutive days. 3, 7

Special Population Considerations

Malnourished Children

Marasmic children have several-fold higher mortality regardless of vitamin A supplementation, though they still benefit from treatment. 5 These children require particularly careful monitoring for complications and may need additional nutritional support. 1

Formulation Considerations

Water-based vitamin A preparations show greater mortality reduction (81%) compared to oil-based preparations (48%), though both are effective. 3 Use whatever formulation is available rather than delaying treatment.